Related Experiment Video
Updated: Mar 18, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Cardiomyopathy in becker muscular dystrophy: Overview
Rady Ho1, My-Le Nguyen1, Paul Mather1
1Rady Ho, My-Le Nguyen, Paul Mather, Department of Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19107, United States.
Becker muscular dystrophy (BMD) is a genetic disorder affecting the dystrophin gene. This paper details the heart complications, including cardiomyopathy, which is the leading cause of death in BMD patients.
Area of Science:
- Cardiology
- Genetics
- Neuromuscular Disorders
Background:
- Becker muscular dystrophy (BMD) is an X-linked recessive genetic disorder.
- Mutations in the dystrophin gene are the underlying cause of BMD.
- Cardiac involvement, specifically cardiomyopathy, is a significant complication in BMD patients.
Purpose of the Study:
- To discuss the pathophysiology of cardiomyopathy in Becker muscular dystrophy.
- To outline the clinical evaluations for cardiac issues in BMD patients.
- To review the management strategies for cardiomyopathy in the context of BMD.
Main Methods:
- Literature review on Becker muscular dystrophy and cardiomyopathy.
- Analysis of existing studies on pathophysiology, clinical presentation, and treatment.
- Synthesis of current knowledge regarding cardiac management in BMD.
Main Results:
- Cardiomyopathy is a primary cause of mortality in Becker muscular dystrophy.
- Understanding the pathophysiology is crucial for effective management.
- Comprehensive clinical evaluation and tailored treatment are essential.
Conclusions:
- Cardiomyopathy poses a significant threat to patients with Becker muscular dystrophy.
- Further research into pathophysiology and treatment is warranted.
- Multidisciplinary management approach is key for improving outcomes in BMD patients with cardiac involvement.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Myocarditis I: Introduction

